![Akihiro Furuta](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Akihiro Furuta
Presidente presso AskAt, Inc.
Posizioni attive di Akihiro Furuta
Società | Posizione | Inizio | Fine |
---|---|---|---|
AskAt, Inc.
![]() AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Direttore/Membro del Consiglio | - | - |
Presidente | - | - |
Storia della carriera di Akihiro Furuta
Precedenti posizioni note di Akihiro Furuta
Società | Posizione | Inizio | Fine |
---|---|---|---|
RAQUALIA PHARMA INC. | Direttore/Membro del Consiglio | 01/07/2008 | - |
Direttore operativo | 08/06/2012 | 01/08/2014 | |
Direttore Tecnico/Scientifico/R&S | 14/07/2011 | 08/06/2012 | |
Ufficiale delle Risorse Umane | 08/06/2012 | 01/08/2014 | |
Corporate Officer/Principal | 01/08/2014 | - |
Formazione di Akihiro Furuta
Nagoya University | Undergraduate Degree |
Oberlin College | Undergraduate Degree |
Statistiche
Distribuzione geografica
Giappone | 4 |
Stati Uniti | 2 |
Posizioni
Director/Board Member | 2 |
Undergraduate Degree | 2 |
Chief Operating Officer | 1 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
RAQUALIA PHARMA INC. | Health Technology |
Aziende private | 1 |
---|---|
AskAt, Inc.
![]() AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Health Technology |
- Borsa valori
- Insiders
- Akihiro Furuta
- Esperienza